Nicholas A. Smith

Array ( [id] => 6454436 [patent_doc_number] => 20100189714 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-29 [patent_title] => 'POLYPEPTIDES WITH ENHANCED ANTI-INFLAMMATORY AND DECREASED CYTOTOXIC PROPERTIES AND RELATING METHODS' [patent_app_type] => utility [patent_app_number] => 12/447204 [patent_app_country] => US [patent_app_date] => 2007-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9084 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0189/20100189714.pdf [firstpage_image] =>[orig_patent_app_number] => 12447204 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4669369 [patent_doc_number] => 20080044429 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-21 [patent_title] => 'Fc.gamma.RIIB-Specific Antibodies and Methods of Use Thereof' [patent_app_type] => utility [patent_app_number] => 11/768852 [patent_app_country] => US [patent_app_date] => 2007-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 70853 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20080044429.pdf [firstpage_image] =>[orig_patent_app_number] => 11768852 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5165275 [patent_doc_number] => 20070286859 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-13 [patent_title] => 'Fc Variants Having Decreased Affinity for FcyRl' [patent_app_type] => utility [patent_app_number] => 11/766581 [patent_app_country] => US [patent_app_date] => 2007-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 69 [patent_figures_cnt] => 69 [patent_no_of_words] => 58630 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20070286859.pdf [firstpage_image] =>[orig_patent_app_number] => 11766581 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5246954 [patent_doc_number] => 20070243188 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-18 [patent_title] => 'Fc Variants Having Decreased Affinity for FcyRlla' [patent_app_type] => utility [patent_app_number] => 11/766596 [patent_app_country] => US [patent_app_date] => 2007-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 70 [patent_figures_cnt] => 70 [patent_no_of_words] => 58630 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0243/20070243188.pdf [firstpage_image] =>[orig_patent_app_number] => 11766596 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5210019 [patent_doc_number] => 20070248603 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-25 [patent_title] => 'Fc Variants with Increased Affinity for FcyRlla' [patent_app_type] => utility [patent_app_number] => 11/766609 [patent_app_country] => US [patent_app_date] => 2007-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 70 [patent_figures_cnt] => 70 [patent_no_of_words] => 58579 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11766609 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5125496 [patent_doc_number] => 20070237767 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-11 [patent_title] => 'Fc Variants Having Decreased Affinity for FcyRllla' [patent_app_type] => utility [patent_app_number] => 11/766624 [patent_app_country] => US [patent_app_date] => 2007-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 70 [patent_figures_cnt] => 70 [patent_no_of_words] => 58638 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0237/20070237767.pdf [firstpage_image] =>[orig_patent_app_number] => 11766624 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5126394 [patent_doc_number] => 20070238665 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-11 [patent_title] => 'Fc Variants Having Decreased Affinity for FcyRIIc' [patent_app_type] => utility [patent_app_number] => 11/765378 [patent_app_country] => US [patent_app_date] => 2007-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 70 [patent_figures_cnt] => 70 [patent_no_of_words] => 58660 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11765378 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5125494 [patent_doc_number] => 20070237765 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-11 [patent_title] => 'Fc Variants Having Increased Affinity for FcyRl' [patent_app_type] => utility [patent_app_number] => 11/765390 [patent_app_country] => US [patent_app_date] => 2007-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 70 [patent_figures_cnt] => 70 [patent_no_of_words] => 58629 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0237/20070237765.pdf [firstpage_image] =>[orig_patent_app_number] => 11765390 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9496730 [patent_doc_number] => 08735545 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-05-27 [patent_title] => 'Fc variants having increased affinity for fcyrllc' [patent_app_type] => utility [patent_app_number] => 11/765353 [patent_app_country] => US [patent_app_date] => 2007-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 69 [patent_figures_cnt] => 72 [patent_no_of_words] => 58519 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11765353 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5125495 [patent_doc_number] => 20070237766 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-11 [patent_title] => 'Fc Variants Having Increased Affinity for FcyRllla' [patent_app_type] => utility [patent_app_number] => 11/765402 [patent_app_country] => US [patent_app_date] => 2007-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 70 [patent_figures_cnt] => 70 [patent_no_of_words] => 58628 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0237/20070237766.pdf [firstpage_image] =>[orig_patent_app_number] => 11765402 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5091690 [patent_doc_number] => 20070231329 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-04 [patent_title] => 'Fc Variants Having Increased Affinity for FcyRIIb' [patent_app_type] => utility [patent_app_number] => 11/764001 [patent_app_country] => US [patent_app_date] => 2007-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 70 [patent_figures_cnt] => 70 [patent_no_of_words] => 58661 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0231/20070231329.pdf [firstpage_image] =>[orig_patent_app_number] => 11764001 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5295994 [patent_doc_number] => 20090010920 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-08 [patent_title] => 'Fc Variants Having Decreased Affinity for FcyRIIb' [patent_app_type] => utility [patent_app_number] => 11/763815 [patent_app_country] => US [patent_app_date] => 2007-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 93 [patent_figures_cnt] => 93 [patent_no_of_words] => 58603 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20090010920.pdf [firstpage_image] =>[orig_patent_app_number] => 11763815 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10013895 [patent_doc_number] => 09056906 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-06-16 [patent_title] => 'Methods for the treatment of autoimmune disorders using immunosuppressive monoclonal antibodies with reduced toxicity' [patent_app_type] => utility [patent_app_number] => 11/763434 [patent_app_country] => US [patent_app_date] => 2007-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 64221 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 138 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11763434 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5248069 [patent_doc_number] => 20070244303 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-18 [patent_title] => 'CD16A Binding Proteins and Use for the Treatment of Immune Disorders' [patent_app_type] => utility [patent_app_number] => 11/757939 [patent_app_country] => US [patent_app_date] => 2007-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 25634 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0244/20070244303.pdf [firstpage_image] =>[orig_patent_app_number] => 11757939 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 92519 [patent_doc_number] => 07732570 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-08 [patent_title] => 'Alteration of Fc-fusion protein serum half-lives by mutagenesis' [patent_app_type] => utility [patent_app_number] => 11/803694 [patent_app_country] => US [patent_app_date] => 2007-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 21366 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/732/07732570.pdf [firstpage_image] =>[orig_patent_app_number] => 11803694 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5062553 [patent_doc_number] => 20070224192 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-27 [patent_title] => 'OPTIMIZED Fc VARIANTS AND METHODS FOR THEIR GENERATION' [patent_app_type] => utility [patent_app_number] => 11/747804 [patent_app_country] => US [patent_app_date] => 2007-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 87868 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20070224192.pdf [firstpage_image] =>[orig_patent_app_number] => 11747804 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 581744 [patent_doc_number] => 07452974 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-11-18 [patent_title] => 'Isolated human squalene synthase and composition thereof' [patent_app_type] => utility [patent_app_number] => 11/797834 [patent_app_country] => US [patent_app_date] => 2007-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 19353 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/452/07452974.pdf [firstpage_image] =>[orig_patent_app_number] => 11797834 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4823648 [patent_doc_number] => 20080227958 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-18 [patent_title] => 'BINDING PROTEINS COMPRISING IMMUNOGLOBULIN HINGE AND FC REGIONS HAVING ALTERED FC EFFECTOR FUNCTIONS' [patent_app_type] => utility [patent_app_number] => 11/735413 [patent_app_country] => US [patent_app_date] => 2007-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 18942 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20080227958.pdf [firstpage_image] =>[orig_patent_app_number] => 11735413 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6433639 [patent_doc_number] => 20100278808 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-04 [patent_title] => 'POLYPEPTIDES WITH ENHANCED ANTI-INFLAMMATORY AND DECREASED CYTOTOXIC PROPERTIES AND RELATING METHODS' [patent_app_type] => utility [patent_app_number] => 12/294883 [patent_app_country] => US [patent_app_date] => 2007-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 9536 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0278/20100278808.pdf [firstpage_image] =>[orig_patent_app_number] => 12294883 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5368790 [patent_doc_number] => 20090306349 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'BINDING PARTNERS WITH IMMUNOGLOBULIN DOMAINS MODIFIED TO HAVE EXTENDED HALF-LIFE' [patent_app_type] => utility [patent_app_number] => 12/295334 [patent_app_country] => US [patent_app_date] => 2007-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 11471 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20090306349.pdf [firstpage_image] =>[orig_patent_app_number] => 12295334 [rel_patent_id] =>[rel_patent_doc_number] =>)